1st Quarter - Report

LEVINE & COMPANY for CIGNA CORPORATION

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$20,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report (this page) Apr 18, 2019 $20,000 Replaced
1st Quarter - Amendment May 22, 2019 $20,000 Replaced
1st Quarter - Termination (No Activity) Jun 12, 2019 $20,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Monitor issues related to drug pricing

LobbyistCovered position, as disclosed
KENNETH LEVINE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Monitor issues related to drug pricing

LobbyistCovered position, as disclosed
KENNETH LEVINE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Pharmacy PHA

Monitor issues related to drug pricing

LobbyistCovered position, as disclosed
KENNETH LEVINE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.